drugset / Trial / NCT01242306

Comparison of Endothelial Dysfunction (BMS vs SES) in the Same Patient With Multiple Coronary Artery Lesions

NCT01242306

Phase 1/2 Completed 25 enrolled Azienda Ospedaliera San Camillo Forlanini
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a prospective, randomised study to compare the endothelial dysfunction of BMS vs SES, both implanted in the same patient with multiple de novo coronary artery lesions undergoing elective PCI. The primary end point will be the evaluation of endothelial dysfunction at 6 months follow-up by measuring the change in vessel diameter in 5 points of the stent and peri-stent site after infusion of acetylcholine.

Timeline

Start
2009-03
Primary completion
2009-11
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetylcholine Small molecule 140 ug Other
Comparator Isosorbide Dinitrate Other / unclassified 2 mg Other
Comparator nitroglycerine Unknown 250 ug Other

Indications

No indication recorded.